Type 2 & other diabetes

Long-Term Glycemic Variability Predicts Adverse Outcomes in Diabetic Heart Failure With Preserved Ejection Fraction

J Clin Endocrinol MetabPublished Retrospective cohort study

Main finding · Hospitalization for HF (HHF)Result — go to the resultHazard ratio 1.32 95% CI 1.04–1.69

Authors' conclusion

Our study highlights a significant association between increased GV and a higher incidence of HHF as well as an elevated overall mortality rate in individuals with diabetes and HFpEF.

Study context

Population
Patients with DM and heart failure with preserved ejection fraction (HFpEF) with FGCV measured, tertiary medical center in Taiwan, 2014–2019from 74,835 with DM
Participants
753 patients
Exposure
Highest vs lowest tertile of fasting glucose coefficient of variability
Outcome
Hospitalization for HF (hospitalization for heart failure (HHF))
Follow-up
Median 38.1 months
Methodological detailssingle tertiary medical center, electronic medical records
  • Single tertiary medical center
  • Electronic medical records

Main finding

As reported in the abstract

Hazard ratio

1.32

95% CI 1.04–1.69

P = 0.025

Third FGCV tertilevs First FGCV tertile
HR 1.32 (95% CI 1.04–1.69); P = 0.025

Observational data: associations, not effects.

Further findings

OutcomeHR (95% CI)P value
Overall mortality · median follow-up 38.1 months1.65 (1.16–2.35)P = 0.005
  • Overall mortality: Kaplan-Meier: log-rank P <.001

Atrial fibrillation (AF) and CV mortality

Highest FGCV tertile not associated with increased AF or CV mortality

Original publication

Long-Term Glycemic Variability Predicts Adverse Outcomes in Diabetic Heart Failure With Preserved Ejection Fraction. J Clin Endocrinol Metab. Published 9 October 2024. doi:10.1210/clinem/dgae715

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.